Search Results 1241-1250 of 19024 for Neutrophil

1. Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial - Mayo Clinic

   Absolute neutrophil count ≥ 1000 cells/mm^3 (obtained ≤ 14 days prior to randomization). Calculated creatinine clearance ≥ 30 mL/min (obtained ≤ 14 days ...

2. Bevacizumab with or without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients with Recurrent Glioblastoma Multiforme - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,500/mm^3; Platelet count ≥ 100,000/mm^3; White blood cells (WBC) ≥ 3,000/mL; Hemoglobin ≥ 10.0 g/dL; note: this level ...

3. Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed Neuroblastoma - Mayo Clinic

   Peripheral absolute neutrophil count (ANC) ≥ 750/uL; Platelet count ≥ 75,000/uL (transfusion independent); Patients known to have bone marrow involvement ...

4. Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet (PLT) ≥ 100,000/mm^3; Total bilirubin ≤ 1.5 upper limit of normal (ULN); Alanine transaminase (ALT) ...

5. NBTXR3 With or Without Cetuximab LA-HNSCC - Mayo Clinic

   Absolute neutrophil count >1500 cells/mm3 5. Alanine aminotransferase (ALT) ≤3 x upper limit of normal (ULN) 6. Aspartate aminotransferase (AST) ≤3×ULN 7 ...

6. Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study - Mayo Clinic

   REGISTRATION: Absolute neutrophil count (ANC) >= 1500/mm^3 (obtained =< 14 days prior to registration); REGISTRATION: Platelet count >= 100,000/mm^3 ...

7. Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients with Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

   The absolute neutrophil count (ANC) must be > 1000 mm^3 prior to starting every cycle of treatment with decitabine; decitabine may be delayed for up to 4 ...

8. A Study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes - Mayo Clinic

   Neutrophil count: <1500/μL,; Platelet count: <150,000 platelets/μL,; Hemoglobin: <10 g/dL,; Aspartate aminotransferase (AST) >2.0 × upper limit of normal (ULN) ...

9. A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Subjects With T-cell Prolymphocytic Leukemia - Mayo Clinic

   absolute neutrophil count (ANC) > 1000/µL (growth factor support is allowed to achieve eligibility criteria);; platelet count > 50,000/µL (platelet ...

10. Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome - Mayo Clinic

    * Absolute neutrophil count \>= 1,500/microliter * Platelets \>= 100,000/microliter * Total bilirubin ≤ institutional upper limit of normal Note: Higher ...